Примери за използване на Pharmacodynamic properties на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
However, the pharmacokinetic and pharmacodynamic properties of soluble insulin aspart have been investigated in children(6-12 years)
The CHMP agreed that the pharmacodynamic properties and the effectiveness of fentanyl are well established
Based on the pharmacodynamic properties of stavudine it is unlikely that Zerit affects the ability to drive
Alternatively, drug interactions may be the result of the pharmacodynamic properties of the drug, e.g.
Do not use 14 days of onset of the laying;- The pharmacodynamic properties have been reworded;- The self life of the veterinary medicinal product as packaged for sale should be 2 years;- The description of the nature and composition of immediate packaging has been harmonized.
The relative differences in the pharmacodynamic properties(GIRmax, AUCGIR,
of these products and supported by data regarding pharmacodynamic properties and by their effects as cough suppressants
However, the pharmacokinetic and pharmacodynamic properties of soluble insulin aspart have been studied in children(6 to 12 years)
of the RANK/RANKL pathway, such as OPG-Fc and RANK-Fc, were used to evaluate the pharmacodynamic properties of denosumab in rodent models.
Pharmacodynamic properties.
Pharmacodynamic properties.
Based on its pharmacodynamic properties, irbesartan is unlikely to affect this ability.
PHARMACOLOGICAL PROPERTIES 5.1 Pharmacodynamic properties Pharmacotherapeutic group:
Based on its pharmacodynamic properties, Irbesartan Hydrochlorothiazide BMS is unlikely to affect this ability.
Overdose following administration of rivaroxaban may lead to haemorrhagic complications due to its pharmacodynamic properties.
Two pharmacodynamic properties of dexrazoxane are described in the literature: Prevention of anthracycline cardiotoxicity.
They differ considerably from one another in terms of their pharmacokinetic and pharmacodynamic properties.
Based on its pharmacodynamic properties, irbesartan is unlikely to affect the ability to drive
Based on its pharmacodynamic properties, nivolumab is unlikely to affect the ability to drive
Given their similar pharmacodynamic properties, these results are also relevant for other ACE-inhibitors